Wegovy manufacturer sues Eli Lilly over false ads

Novo Nordisk has filed a lawsuit against Eli Lilly, accusing the company of false and misleading advertising regarding their weight-loss medications. The lawsuit alleges that Lilly's ads compare high doses of Lilly's drugs to lower doses of Novo's products, misleading consumers about their relative effectiveness. Novo is asking for a court order to stop Lilly's comparison ads and to require corrective advertising, amid intense market competition for GLP-1 weight-loss drugs.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل